Gerard J. Criner, MD, FACP, FACCP, outlines the details of the Gala Therapeutics RheSolve Study for treating patients with chronic bronchitis.
Related Presenters
Gerard Criner, MD, FACP, FACCP
Director, Temple Lung Center
Gerard Criner, MD is an internationally renowned pulmonologist and Temple’s clinical investigator in advanced lung diseases,COPD, pulmonary fibrosis, respiratory failure, and COVID-19. Dr. Criner is a board member for the Global Initiative ...
Related Videos
